This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. advanced 4.5% to $11.88 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 23,214.69 and the Dow Jones Industrial Average rising 0.7% to 47,427.12.
The stock's rise snapped a two-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed 42.2% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 6.0% to $5.30, Fortress Biotech Inc. rose 2.6% to $2.76, and Viking Therapeutics Inc. rose 2.28% to $36.27.
Trading volume totaled 129,042, compared to the 50-day average of 412,772.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 26, 2025 16:34 ET (21:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments